{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:46:52Z","timestamp":1770752812831,"version":"3.50.0"},"reference-count":15,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>Relapsing polychondritis and Sweet\u2019s syndrome are rare systemic inflammatory conditions. The authors present a patient who developed Sweet\u2019s syndrome 1 week after adalimumab therapy for refractory relapsing polychondritis. Coexistent relapsing polychondritis and Sweet\u2019s syndrome is rare, however, is likely to represent a true disease association and signifies a high risk of myelodysplasia. Antitumour necrosis factor \u03b1 (TNF\u03b1) therapy is a treatment option in both relapsing polychondritis and Sweet\u2019s syndrome, and switching anti-TNF\u03b1 agents may be feasible in the event of adverse reaction.<\/jats:p>","DOI":"10.1136\/bcr.10.2011.4935","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T09:44:26Z","timestamp":1324547066000},"page":"bcr1020114935","source":"Crossref","is-referenced-by-count":14,"title":["Sweet\u2019s syndrome after adalimumab therapy for refractory relapsing polychondritis"],"prefix":"10.1136","volume":"2011","author":[{"given":"Sarah","family":"Keidel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aubretia","family":"McColl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Edmonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2011,12,22]]},"reference":[{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.1","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1365-2141.1995.tb08420.x","article-title":"Bone marrow pathology in relapsing polychondritis: high frequency of myelodysplastic syndromes.","volume":"89","author":"Diebold","year":"1995","journal-title":"Br J Haematol"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.2","first-page":"1413","article-title":"Treatment of relapsing polychondritis with a TNF antagonist.","volume":"32","author":"Carter","year":"2005","journal-title":"J Rheumatol"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem229"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.4","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(93)90112-P"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.5","doi-asserted-by":"publisher","DOI":"10.4065\/70.3.234"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.6","doi-asserted-by":"publisher","DOI":"10.1080\/17402520500134254"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.11.1089"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.8","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.9.1170"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.9","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200105000-00003"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.10","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0488"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02198.x"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02536.x"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.1.81"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.14","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0263"},{"key":"2025082722144043000_2011.dec21_1.bcr1020114935.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02197.x"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr.10.2011.4935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:14:48Z","timestamp":1756358088000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr.10.2011.4935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,22]]},"references-count":15,"alternative-id":["10.1136\/bcr.10.2011.4935"],"URL":"https:\/\/doi.org\/10.1136\/bcr.10.2011.4935","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,22]]}}}